Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole versus lactic acid gel for bacterial vaginosis
ISRCTN14161293Phase 3Completed
- Sponsor
- University Hospitals Birmingham
- Start
- Sep 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in bacterial vaginosis (BV) comparing Intravaginal lactic acid gel with Oral metronidazole (2 arms). Primary endpoint: Primary: Resolution of bacterial vaginosis symptoms at 2 weeks. Started Sep 2017; status: completed.
02
Drugs
metronidazolelactic acid
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ISRCTN14161293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14161293.